Taking near-term challenges into account
28/09/22 -"Overall, Sonova remains our preferred hearing aids bet, largely banking on the potential benefits associated with newer and innovative offerings. This optimism also reflects in the relative valuation ..."
Pages
59
Language
English
Published on
28/09/22
You may also be interested by these reports :
24/04/24
Getinge reported a mixed set of results, missing top-line estimates marginally but beating on profit and order intake. Investors cheered the latter, ...
23/04/24
We have factored the 2023 actual figures into our model ahead of the availability of the annual report and more detailed information. The difference ...
22/04/24
Sartorius Stedim reported softer-than-expected Q1 24 numbers, missing the consensus by 5.7%/3.4% on the top line/bottom line, respectively. The ...
22/04/24
Sartorius reported softer-than-expected Q1 24 numbers, missing the consensus by 5.4% on the top line, but beating (+2.4%) on the bottom line. The ...